Capital marketers, insurance and wealth management experts, investment bankers, individual investors, and research analysts, are invited to attend the Dawson James Small Cap Growth Conference to be held in Wyndham Grand Harborside Jupiter, Jupiter, FL, October 12, 2023. The distinguished conference serves as a hallmark in the financial world, featuring important management experts slated to share cutting-edge innovations, strategies, and growth opportunities.
The highly anticipated 8th Annual Investor Conference provides a unique platform for evolving and established small-cap growth companies within the healthcare, technology, and consumer sectors. It’s a unique opportunity for ground-breaking businesses to showcase their products and services to a wide audience. The conference promises to provide ample networking opportunities to business owners who are eager to revolutionize the industry and deliver an enhanced ROI.
Promoting Investment Excellence
The Dawson James Small Cap Growth Conference will be dignified by a select, invite-only audience, that includes Institutional Funds, Family Offices, and a significant base of High Net Worth Accredited Investors. As an incredible blend of the brightest minds and opportunities, the conference aims to leverage the massive potential that small-cap growth companies offer. This rare gathering of professionals and extraordinary minds will explore a diverse range of investment prospects to set the tone for the day.
The core of the conference lies in the business presentations, where selected small-cap growth companies will take the stage. The conference will start at 7:30 a.m. with registration and a hearty breakfast to fuel participants for the exciting day ahead. Following the breakfast, a panel of eminent professionals will delve into the current investment setting, sharing valuable perspectives and insights into the growth potential and investment opportunities.
Register today and be a part of small-cap growth and innovation.
Participating Companies as of 09/19/2023
- Aditxt, Inc. (NASDAQ: ADTX) (www.Aditxt.com)
- Annovis Bio Inc. (NYSE American: ANVS) (www.AnnovisBio.com)
- bioAffinity Technologies, Inc. (NASDAQ: BIAF) (https://bioaffinitytech.com)
- Bitfarms (NASDAQ: BITF) (https://Bitfarms.com/)
- Borqs Technologies, Inc. (NASDAQ: BRQS) (www.Borqs.com)
- Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) (www.CitiusPharma.com)
- Clearmind Medicine Inc. (NASDAQ: CMND) (www.ClearmindMedicine.com)
- Cyclo Therapeutics (NASDAQ: CYTH) (https://cyclotherapeutics.com)
- CytoSorbents Corporation (NASDAQ: CTSO) (https://CytoSorbents.com)
- Dawson James Securities (https://DawsonJames.com)
- Digital Health Acquisition Corp. (NASDAQ: DHAC) (https://DigitalHealthAcquisition.com)
- GeoVax Labs, Inc. (NASDAQ: GOVX) (www.GeoVax.com)
- HealthBeacon (OTCQX: HBCN) (https://HealthBeacon.com)
- Heartbeam, Inc. (NASDAQ: BEAT) (www.HeartBeam.com)
- Hillstream BioPharma, Inc. (NASDAQ: HILS) (https://HillstreamBio.com)
- Innovative Eyewear Inc, (NASDAQ: LUCY) (https://Lucyd.co)
- Inuvo Inc. (NYSE American: INUV) (https://Inuvo.com)
- JanOne, Inc. (NASDAQ: JAN) (https://JanOne.com)
- Janover Inc. (NASDAQ: JNVR) (https://JanOver.co)
- Kintara Therapeutics, Inc. (NASDAQ: KTRA) (www.Kintara.com)
- Matinas Biopharma Holdings, Inc. (NYSE American: MTNB) (www.MatinasBiopharma.com)
- NextPlat Corp. (NASDAQ: NXPL) (www.NextPlat.com)
- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (https://NovaBay.com)
- Neuro Rx Pharmaceuticals (NASDAQ: NRXP) (www.NRXPharma.com)
- Red Cat Holdings, Inc. (NASDAQ: RCAT) (https://RedCat.red)
- SeaStar Medical Holding Corp. (NASDAQ: ICU) (https://SeaStarMedical.com)
- SKYX Platforms Corp. (NASDAQ: SKYX) (https://SkyPlug.com)
- Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) (https://SonomaPharma.com)
- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (www.StrataSkinSciences.com)
- Windtree Therapeutics, Inc. (NASDAQ: WINT) (https://WindtreeTX.com)
- Wisa Technologies (NASDAQ: WISA) (www.WisaTechnologies.com)
- ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (www.ZIVOBioscience.com)
- Zomedica Corp. (NYSE American: ZOM) (https://Zomedica.com)
Platinum Sponsors as of 09/19/2023
- ArentFox Schiff LLP (www.AFSLaw.com)
- Sicheniza Ross Ference Carmel LLP (https://SRF.Law)
- IBN (InvestorBrandNetwork) (www.InvestorBrandNetwork.com)
- IRTH Communications, LLC (www.IRTHCommunications.com)
- SLS Group (www.SLSGroup.io)
- The Money Channel (www.MoneyChannelNYC.com)
Other Sponsors as of 09/19/2023
- Core IR (https://CoreIR.com)
- Greenberg Traurig, PA (https://www.GTLaw.com/en/)
- Jaisin LLC (https://Jaisin.com/Los-Angeles/)
- Skyline Corporate Communications (https://SkylineCCG.com)
- Group, LLC (http://Group-LLC.com)
- The Nuvo Group, Inc (www.TheNuvoGroup.com)
- The Vendor Group (www.TheVendorGroup.com)
- Wall Street Reporting
To learn more, please visit https://nnw.fm/W0l7l
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer
NetworkNewsWire
New York, NY
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is powered by IBN
